CRISPR-Cas-based pen-side diagnostic tests for Anaplasma marginale and Babesia bigemina
| dc.creator | Muriuki, Robert | |
| dc.creator | Ndichu, M. | |
| dc.creator | Githigia, S. | |
| dc.creator | Svitek, Nicholas | |
| dc.date | 2024-12-15 | |
| dc.date | 2025-01-02T07:32:17Z | |
| dc.date | 2025-01-02T07:32:17Z | |
| dc.date.accessioned | 2026-06-27T17:15:51Z | |
| dc.description | <i>Anaplasma marginale</i> and <i>Babesia bigemina</i> are tick-borne pathogens, posing significant threats to the health and productivity of cattle in tropical and subtropical regions worldwide. Currently, detection of <i>Babesia bigemina</i> and <i>Anaplasma marginale</i> in infected animals relies primarily on microscopic examination of Giemsa-stained blood or organ smears, which has limited sensitivity. Molecular methods offer higher sensitivity but are costly and impractical in resource-limited settings. Following the development of a pen-side test for detecting <i>Theileria parva</i> infections in cattle, we have created two additional CRISPR-Cas12a assays targeting <i>Anaplasma marginale</i> and <i>Babesia bigemina</i>. The assays target the major surface protein 5 (MSP5) for <i>A. marginale</i> and rhoptry-associated protein 1a (RAP1a) for <i>B. bigemina</i>. These additional tests involve a 20 min recombinase polymerase amplification (RPA) reaction followed by a 60 min CRISPR-Cas12a detection with a lateral strip readout. Results demonstrate high specificity, with no cross-reactivity against other tick-borne parasites, and a limit of detection down to 102 DNA copies/µL of each target marker. The findings pave the way for sensitive and user-friendly pen-side tests to diagnose <i>A. marginale</i> and <i>B. bigemina</i> infections. | |
| dc.identifier | https://hdl.handle.net/10568/168463 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/147102 | |
| dc.language | en | |
| dc.publisher | MDPI | |
| dc.rights | Open Access | |
| dc.source | Muriuki, R., Ndichu, M., Githigia, S. and Svitek, N. 2024. CRISPR-Cas-based pen-side diagnostic tests for <i>Anaplasma marginale</i> and <i>Babesia bigemina</i>. Microorganisms 12(12): 2595. | |
| dc.subject | crispr | |
| dc.subject | diagnosis | |
| dc.title | CRISPR-Cas-based pen-side diagnostic tests for Anaplasma marginale and Babesia bigemina | |
| dc.type | Journal Article |
